
    
      The neonates who are being treated at the University of Florida Health Neonates Intensive
      Care Unit and are anticipated to need more than 21 days of intravenous nutrition will be
      considered as potential subjects. These subjects will receive the unique formulation of
      SMOFLipid

      The following data will be collected from the subject's EMR by members of the research team:

        -  Lab values that evaluate liver function

        -  Growth parameters like head circumference, length, weight

        -  Medical/surgical history

        -  Time to resolution of bilirubin, time to liver transplant, time to death

        -  Length of hospital stay

        -  Rates of blood infections

      Subjects will remain on SMOFlipid until weaned from PN.
    
  